脊椎增強術市場規模、佔有率和成長分析（按手術類型、器械類型、材料類型、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

全球椎體增強市場規模預計在 2024 年達到 32.9 億美元，從 2025 年的 34.6 億美元成長到 2033 年的 52 億美元，在預測期（2026-2033 年）內複合年成長率為 5.2%。

全球椎體增強術市場的主要驅動力是骨質疏鬆症和脊椎疾病的日益增加以及人口老化。微創手術技術的進步進一步加速了市場動態。更嚴格的監管指南確保了病人安全和手術有效性，增強了醫生和病人對所用材料品質的信心。不斷增加的研發投入催生了創新醫療設備，這些器械將椎體高度恢復和骨水泥注射等多種功能整合到一個統一的系統中。隨著技術創新提高效率並降低醫療成本，對微創脊椎手術的需求不斷成長。此外，專科診所和門診手術中心的增加擴大了病患的就醫管道，而病患對先進治療方案的偏好變化也進一步推動了市場擴張。

推動全球椎體增強市場發展的因素

全球人口老化加劇是椎體成形術市場的主要促進因素。骨質疏鬆症在老年族群中十分常見，導致骨骼脆弱，骨折風險增加。因此，這種人口結構變化導致椎體壓迫性骨折（VCF）的發生率上升，進而推動了對後凸成形術和椎體後凸成形術等有效治療方法的需求。這些手術不僅可以緩解疼痛，還能改善VCF患者的活動能力。隨著老年人口的持續成長，對椎體成形術治療的持續需求預計將推動市場成長。

全球椎體增強治療市場的限制因素

椎體強化手術的高昂費用是其市場擴張的一大障礙。這筆費用涵蓋醫療設備、手術介入、住院治療和術後護理等各個面向。對於部分患者而言，尤其是那些居住在醫療保險覆蓋不足或社會經濟地位較低的地區的患者，這些費用可能難以承受，導致他們無法接受治療。因此，經濟壓力可能導致治療延誤，或促使患者選擇費用較低的保守治療方案，例如止痛藥或矯正器具。椎體強化手術的高昂費用阻礙了其市場滲透，限制了此類治療方法的廣泛應用。

全球椎體增強術市場趨勢

全球椎體增強術市場正經歷著向微創治療的顯著轉變，這反映了醫療保健領域的整體趨勢。椎體成形術和椎體增強術等技術因其切口小、出血少、住院時間短等優勢而備受關注。科技進步不斷提升這些手術的安全性和精準度，與外科醫師和病患對微創治療方案日益成長的需求不謀而合。這種日益成長的偏好正在推動器材研發的創新，最終帶來更佳的臨床療效，並促進市場的強勁成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 一手和二手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 用例
• 技術評估
• 監管環境

全球脊椎增強術市場規模（按手術類型和複合年成長率分類）（2026-2033 年）

• 椎體成形術
• 後凸成形術

全球脊椎增強市場規模（按器材類型和複合年成長率分類）（2026-2033 年）

• 椎體成形術裝置
• 椎體成形術裝置
• 骨通路裝置
• 其他

全球脊椎增強市場規模（按材料類型和複合年成長率分類）（2026-2033 年）

• 水泥
• 生物材料
• 骨移植材料
• 其他

全球脊椎增強術市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 骨質疏鬆症
• 椎體骨折
• 瘤

全球脊椎增強市場規模（按最終用戶和複合年成長率分類）（2026-2033 年）

• 醫院
• 門診手術中心（ASC）
• 專科診所
• 創傷中心

全球脊椎增強術市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

  主要企業簡介

  • 美敦力公司（愛爾蘭）
  • 強生公司（美國）
  • 史賽克公司（美國）
  • Globus Medical Inc.（美國）
  • Zimmer Biomet Holdings, Inc.（美國）
  • NuVasive公司（美國）
  • Orthofix Medical Inc.（美國）
  • B. Braun Melsungen AG（Aesculap）（德國）
  • Merit Medical Systems, Inc.（美國）
  • IZI醫療產品（美國）
  • Zavation（美國）
  • RONTIS（瑞士）
  • BPB Medica Srl（義大利）
  • 斯皮內爾特（瑞士）
  • SeaSpine（美國）
  • Accutus Medical（美國）
  • 安全骨科（法國）

結論與建議

Global Vertebral Augmentation Market size was valued at USD 3.29 Billion in 2024 and is poised to grow from USD 3.46 Billion in 2025 to USD 5.2 Billion by 2033, growing at a CAGR of 5.2% in the forecast period (2026-2033).

The global vertebral augmentation market is primarily driven by the increasing prevalence of osteoporosis and spinal disorders, alongside an aging population. Advancements in minimally invasive surgical techniques are further enhancing market dynamics. Stricter regulatory guidelines ensure patient safety and procedural effectiveness, instilling confidence among both physicians and patients regarding the quality of materials used. Increased investment in research and development is leading to innovative medical devices that streamline various functions, such as vertebral height restoration and cement injection, into unified systems. As technological innovations improve efficiency and reduce healthcare costs, the demand for minimally invasive spinal procedures rises. Additionally, the growth of specialty clinics and ambulatory surgical centers expands patient access, while shifting preferences towards advanced treatment options drive further market expansion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Vertebral Augmentation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Vertebral Augmentation Market Segments Analysis

Global Vertebral Augmentation Market is segmented by Procedure Type, Device Type, Material Type, Application, End-User and region. Based on Procedure Type, the market is segmented into Vertebroplasty and Kyphoplasty. Based on Device Type, the market is segmented into Vertebroplastic Devices, Kyphoplastic Devices, Bone Access Devices and Others. Based on Material Type, the market is segmented into Cement, Biomaterials, Bone Grafts and Others. Based on Application, the market is segmented into Osteoporosis, Spinal Fractures and Tumors. Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers (ASCs), Specialty Clinics and Trauma Centers. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Vertebral Augmentation Market

The expanding elderly population worldwide serves as a significant catalyst for the vertebral augmentation market. As osteoporosis frequently affects older individuals, it leads to an increased risk of fractures due to bone weakening. Consequently, this demographic shift contributes to a higher incidence of vertebral compression fractures (VCFs), which in turn drives the demand for effective treatment options like kyphoplasty and vertebroplasty. These procedures not only alleviate pain but also improve mobility for patients suffering from VCFs. As the number of elderly individuals continues to increase, the ongoing demand for vertebral augmentation treatments is expected to propel market growth.

Restraints in the Global Vertebral Augmentation Market

The high cost associated with vertebral augmentation procedures presents a substantial obstacle to market expansion. This financial burden encompasses expenses for the device, surgical intervention, hospitalization, and post-operative care. Many patients, particularly those in regions with inadequate healthcare coverage or lower socioeconomic conditions, may find these costs prohibitive. Consequently, the financial pressure can lead to delays in receiving treatment or the adoption of less expensive, more conservative options such as pain relief medications or brace usage. Ultimately, the significant expense linked to vertebral augmentation procedures hinders market penetration and restricts broader acceptance of these interventions.

Market Trends of the Global Vertebral Augmentation Market

The Global Vertebral Augmentation market is experiencing a notable shift towards minimally invasive treatments, underscoring a broader trend in the medical field. Techniques like kyphoplasty and vertebroplasty are gaining traction due to their advantages, including reduced incisions, lower blood loss, and shorter hospital stays. Advancements in technology are enhancing the safety and precision of these procedures, aligning with the increasing demand from both surgeons and patients for less invasive options. This growing preference is fostering innovation in device development, ultimately leading to improved clinical outcomes and contributing to the robust expansion of the market.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• Pestel Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Assessment
• Regulatory Landscape

Global Vertebral Augmentation Market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Vertebroplasty
• Kyphoplasty

Global Vertebral Augmentation Market Size by Device Type & CAGR (2026-2033)

• Market Overview
• Vertebroplastic Devices
• Kyphoplastic Devices
• Bone Access Devices
• Others

Global Vertebral Augmentation Market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Cement
• Biomaterials
• Bone Grafts
• Others

Global Vertebral Augmentation Market Size by Application & CAGR (2026-2033)

• Market Overview
• Osteoporosis
• Spinal Fractures
• Tumors

Global Vertebral Augmentation Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Specialty Clinics
• Trauma Centers

Global Vertebral Augmentation Market Size & CAGR (2026-2033)

• North America (Procedure Type, Device Type, Material Type, Application, End-User)
  • US
  • Canada
• Europe (Procedure Type, Device Type, Material Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Procedure Type, Device Type, Material Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Procedure Type, Device Type, Material Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Procedure Type, Device Type, Material Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Globus Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NuVasive, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Orthofix Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Aesculap)(Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merit Medical Systems, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IZI Medical Products (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zavation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• RONTIS (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BPB Medica S.r.l. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spineart (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SeaSpine (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Accutus Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Safe Orthopaedics (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations